The Positives
+ Gains on investment holdings continue stave off slower business momentum.
Other non-interest income jumped 45% YoY in 2Q20 due to profit realisation from fixed income securities. This contributed to a 3.6x jump in net income from investment securities in 1H20 to S$663mn from S$184mn in 1H19.
The bank has noted that it is currently holding S$1.5bn of unrealised mark-to-market gains in investment securities. This may allow the bank to provide income buffer against the weakness observed across other income sources.
The Negatives
– NII fell 5% YoY in 2Q20 as NIM was compressed 29 bps from 1.91% in 2Q19 to 1.62%.
The quarter saw full impact of the double interest rate cuts in March. However, loans growth of 7% YoY muted the impact of NIM compression on NII. NIM for 1H20 was held up by a resilient 1Q20, coming in at 1.74%, 16 bps lower than 1H19 of 1.90%.
With asset pricing adjustments lagging loans pricing, we expect NIM to stabilise at current levels, which will see NIM coming in at 1.68% for the entire FY20.
– Fee income fell 11% YoY in 2Q20 due to lower business activity in the quarter from Circuit Breaker measures.
However, 1H20 fee income came relatively stable (+1%) at S$1.75bn from 1H19 as fee income from 1Q20 was up 14% YoY. Brokerage fees were up 25% YoY from S$59mn in 1H19 to $74mn in 1H20, but was offset by lower investment banking fee and credit card fees of S$63mn (-19%) and S$304mn (-21%) respectively from S$78mn and S$387mn in 1H19. Business momentum should return gradually as economic activities resume, with wealth management fee looking to benefit with face-to-face interactions between the bank and its customers.
Outlook
Quarterly dividend was cut to S$0.18 per share from S$0.33 QoQ with 60% cap stipulated by MAS.
Under MAS guidance to cap dividends for FY20, dividends will be capped at S$0.18 for the next 4 quarters to 1Q20, bringing FY20e distribution to $0.87, down 30% from FY19 distribution of $1.23. We expect dividends to go back to previous levels of S$0.33 per quarter by 3Q21, which will bring FY21 distribution to S$1.02.
Option for scrip dividend will be available through the next four quarters but without any discount as the bank sees no need to further conserve capital.
Reserves build-up well underway and expected to taper in FY21.
For 1Q20, DBS has set aside an additional S$560mn in GP allowances, bringing YTD GP allowances to S$1.26bn. This is in line with management guidance of 80 – 130 bps in credit costs amounting to S$3 – 5bn to be booked by end of FY21.
We expect book-building to occur and similar rate for the next 2 quarters and taper slightly to S$0.5bn per quarter in FY21.
Investment Actions
We maintain our ACCUMULATE recommendation with a revised TP of S$21.00 (prev. S$20.60). We have revised income upwards with resilience observed from non-interest income providing buffer to weakness from NII. CET-1 ratio for DBS remains healthy at 13.7% in 2Q20 compared to 13.6% a year ago.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note: